Drugs / MTX
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01238328 Background | Sep 2009 → Sep 2012 | mucopolysaccharidosis | Tehran University of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX | “MTX” NCT01238328 ↗ |
| Route | Intravenous | “10 mg/m\^2 iv day +1 then 6 mg/m\^ iv day +3 and +6” NCT01238328 ↗ |